BEGIN:VCALENDAR
VERSION:2.0
X-WR-CALNAME:EventsCalendar
PRODID:-//hacksw/handcal//NONSGML v1.0//EN
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/New_York
LAST-MODIFIED:20240422T053451Z
TZURL:https://www.tzurl.org/zoneinfo-outlook/America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
TZNAME:EDT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZNAME:EST
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
CATEGORIES:College of Arts and Sciences,Thesis/Dissertations
DESCRIPTION:Title: Targeting HIV-1 Nef Functions: Inhibitor Development and
  Structural Characterization Advisors:  Dr. Shuowei Cai, Professor, Depar
 tment of Chemistry & Biochemistry, University of Massachusetts Dartmouth &
  Dr. Xiaofei Jia, Associate Professor, Department of Biomedical Sciences, 
 Florida State University Committee Members:  Dr. Catherine Neto, Professo
 r, Department of Chemistry & Biochemistry, University of Massachusetts Dar
 tmouth &  Dr. Tracie Ferreira, Professor, Department of Bioengineering, U
 niversity of Massachusetts Dartmouth Abstract: Human immunodeficiency viru
 s type 1 (HIV-1) remains a major global health challenge despite significa
 nt advances in antiretroviral therapy (ART). Although ART effectively supp
 resses viral replication, it does not eliminate persistent viral reservoir
 s, highlighting the need for alternative therapeutic strategies. The HIV-1
  accessory protein Nef plays a critical role in viral pathogenesis. It med
 iates viral immune evasion by downregulating host cell surface proteins, i
 ncluding CD4 and the antiviral restriction factor SERINC5. Inhibition of N
 ef-mediated CD4 downregulation may restore cell-surface CD4 expression and
  enhance antibody-dependent cellular cytotoxicity (ADCC), whereas understa
 nding the structural mechanism of SERINC5 downregulation may provide furth
 er insight into Nef-mediated viral immune evasion. This dissertation focus
 es on the development of inhibitors targeting Nef-mediated CD4 downregulat
 ion and the structural investigation of Nef-mediated SERINC5 downregulatio
 n. Chapter 2 describes the development and optimization of a homogeneous t
 ime-resolved fluorescence resonance energy transfer (TR-FRET) assay to ide
 ntify inhibitors of the Nef-CD4 interaction. Two assay formats, FRET(CD4) 
 and FRET(CD4)fusion, were established and demonstrated excellent suitabili
 ty for high-throughput screening, with Z′ factors of 0.63 and 0.76, resp
 ectively. A pilot screen of 640 compounds identified a potential inhibitor
 , which exhibited concentration-dependent inhibition of the Nef-CD4 intera
 ction. Chapter 3 focuses on the development and biochemical characterizati
 on of CD4-mimetic cyclic peptides designed to disrupt the Nef-CD4 interact
 ion. Using the CD4 cytoplasmic domain as the original template, libraries 
 of cyclic peptides were generated, the members of which differ from one an
 other on sequence compositions. Hits with superior binding affinities towa
 rd the Nef-AP2 complex were selected, with dissociation constants ranging 
 from 34 μM to 0.11 μM. Biochemical assays, including size-exclusion chro
 matography and TR-FRET competition assays, provided preliminary evidence o
 f Nef binding and inhibitory activity for selected cyclic peptides, suppor
 ting their potential as inhibitor candidates for further development. Chap
 ter 4 investigates the structural organization of the Nef-SERINC5-AP2 comp
 lex using cryo-electron microscopy (cryo-EM). A Nef-S5L9 fusion construct 
 was successfully expressed, purified, and assembled with a hemicomplex of 
 AP2. Chemical cross-linking stabilized the complex for cryo-EM analysis. T
 hree-dimensional reconstruction yielded a density map at approximately 7.6
 4 Å resolution. Docking of the Nef-AP2 structure revealed additional dens
 ity that may correspond to S5L9, providing preliminary structural insight 
 into the organization of the complex. However, the limited dataset and res
 olution prevented confident assignment of this density and determination o
 f the molecular interactions underlying SERINC5 recognition. Nevertheless,
  this study established an alternative protein construct and sample prepar
 ation strategy for future structural investigations. Collectively, these s
 tudies establish a robust screening platform for Nef inhibitor discovery, 
 identify CD4-mimetic cyclic peptides as potential Nef inhibitors, and adva
 nce the structural investigation of Nef-mediated SERINC5 downregulation. T
 hese findings contribute to understanding HIV-1 Nef-host protein interacti
 ons and support the development of therapeutic strategies targeting Nef-me
 diated immune evasion. Zoom Meeting ID: 992 1869 8257\nEvent page: https:/
 /www.umassd.edu/events/cms/12-22-26-defense-by-fatema-yeasmin-targeting-hi
 v-1-nef-functions-inh.php\nEvent link: https://fsu.zoom.us/j/99218698257
X-ALT-DESC;FMTTYPE=text/html:<html><body><p>Title: Targeting HIV-1 Nef Func
 tions: Inhibitor Development and Structural Characterization</p>\n<p>Advis
 ors:  Dr. Shuowei Cai\, Professor\, Department of Chemistry & Biochemistr
 y\, University of Massachusetts Dartmouth & Dr. Xiaofei Jia\, Associate Pr
 ofessor\, Department of Biomedical Sciences\, Florida State University</p>
 \n<p>Committee Members:  Dr. Catherine Neto\, Professor\, Department of C
 hemistry & Biochemistry\, University of Massachusetts Dartmouth &  Dr. Tr
 acie Ferreira\, Professor\, Department of Bioengineering\, University of M
 assachusetts Dartmouth</p>\n<p>Abstract:</p>\n<p>Human immunodeficiency vi
 rus type 1 (HIV-1) remains a major global health challenge despite signifi
 cant advances in antiretroviral therapy (ART). Although ART effectively su
 ppresses viral replication\, it does not eliminate persistent viral reserv
 oirs\, highlighting the need for alternative therapeutic strategies. The H
 IV-1 accessory protein Nef plays a critical role in viral pathogenesis. It
  mediates viral immune evasion by downregulating host cell surface protein
 s\, including CD4 and the antiviral restriction factor SERINC5. Inhibition
  of Nef-mediated CD4 downregulation may restore cell-surface CD4 expressio
 n and enhance antibody-dependent cellular cytotoxicity (ADCC)\, whereas un
 derstanding the structural mechanism of SERINC5 downregulation may provide
  further insight into Nef-mediated viral immune evasion. This dissertation
  focuses on the development of inhibitors targeting Nef-mediated CD4 downr
 egulation and the structural investigation of Nef-mediated SERINC5 downreg
 ulation.</p>\n<p>Chapter 2 describes the development and optimization of a
  homogeneous time-resolved fluorescence resonance energy transfer (TR-FRET
 ) assay to identify inhibitors of the Nef-CD4 interaction. Two assay forma
 ts\, FRET(CD4) and FRET(CD4)fusion\, were established and demonstrated exc
 ellent suitability for high-throughput screening\, with Z′ factors of 0.
 63 and 0.76\, respectively. A pilot screen of 640 compounds identified a p
 otential inhibitor\, which exhibited concentration-dependent inhibition of
  the Nef-CD4 interaction.</p>\n<p>Chapter 3 focuses on the development and
  biochemical characterization of CD4-mimetic cyclic peptides designed to d
 isrupt the Nef-CD4 interaction. Using the CD4 cytoplasmic domain as the or
 iginal template\, libraries of cyclic peptides were generated\, the member
 s of which differ from one another on sequence compositions. Hits with sup
 erior binding affinities toward the Nef-AP2 complex were selected\, with d
 issociation constants ranging from 34 μM to 0.11 μM. Biochemical assays\
 , including size-exclusion chromatography and TR-FRET competition assays\,
  provided preliminary evidence of Nef binding and inhibitory activity for 
 selected cyclic peptides\, supporting their potential as inhibitor candida
 tes for further development.</p>\n<p>Chapter 4 investigates the structural
  organization of the Nef-SERINC5-AP2 complex using cryo-electron microscop
 y (cryo-EM). A Nef-S5L9 fusion construct was successfully expressed\, puri
 fied\, and assembled with a hemicomplex of AP2. Chemical cross-linking sta
 bilized the complex for cryo-EM analysis. Three-dimensional reconstruction
  yielded a density map at approximately 7.64 Å resolution. Docking of the
  Nef-AP2 structure revealed additional density that may correspond to S5L9
 \, providing preliminary structural insight into the organization of the c
 omplex. However\, the limited dataset and resolution prevented confident a
 ssignment of this density and determination of the molecular interactions 
 underlying SERINC5 recognition. Nevertheless\, this study established an a
 lternative protein construct and sample preparation strategy for future st
 ructural investigations.</p>\n<p>Collectively\, these studies establish a 
 robust screening platform for Nef inhibitor discovery\, identify CD4-mimet
 ic cyclic peptides as potential Nef inhibitors\, and advance the structura
 l</p>\n<p>investigation of Nef-mediated SERINC5 downregulation. These find
 ings contribute to understanding HIV-1 Nef-host protein interactions and s
 upport the development of therapeutic strategies targeting Nef-mediated im
 mune evasion.</p>\n<p>Zoom Meeting ID: 992 1869 8257</p><p>Event page: <a 
 href="https://www.umassd.edu/events/cms/12-22-26-defense-by-fatema-yeasmin
 -targeting-hiv-1-nef-functions-inh.php">https://www.umassd.edu/events/cms/
 12-22-26-defense-by-fatema-yeasmin-targeting-hiv-1-nef-functions-inh.php</
 a><br>Event link: <a href="https://fsu.zoom.us/j/99218698257">https://fsu.
 zoom.us/j/99218698257</a></p></body></html>
DTSTAMP:20261120T215744
DTSTART;TZID=America/New_York:20261222T140000
DTEND;TZID=America/New_York:20261222T160000
LOCATION:Zoom
SUMMARY;LANGUAGE=en-us:"Targeting HIV-1 Nef Functions: Inhibitor Developmen
 t and Structural Characterization"
UID:824e22463e6f59c22e1ad5bec45bff2a@www.umassd.edu
END:VEVENT
END:VCALENDAR
